HB Wealth Management’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Buy
11,145
+653
+6% +$47.8K ﹤0.01% 897
2026
Q1
$801K Buy
10,492
+2,178
+26% +$157K 0.01% 758
2025
Q4
$531K Buy
8,314
+3,631
+78% +$224K ﹤0.01% 882
2025
Q3
$295K Sell
4,683
-2,250
-32% -$157K ﹤0.01% 1081
2025
Q2
$518K Sell
6,933
-3,181
-31% -$250K ﹤0.01% 732
2025
Q1
$891K Buy
10,114
+4,760
+89% +$449K 0.01% 571
2024
Q4
$489K Buy
5,354
+3,063
+134% +$314K 0.01% 628
2024
Q3
$257K Buy
2,291
+206
+10% +$20.6K ﹤0.01% 813
2024
Q2
$204K Buy
+2,085
New +$207K ﹤0.01% 846
2023
Q4
– Sell
-3,049
Closed -$234K – 800
2023
Q3
$234K Buy
+3,049
New +$253K ﹤0.01% 656

Other funds holding EMN

HB Wealth Management's EMN Position: Q2 2026 in Review

HB Wealth Management increased its Eastman Chemical (EMN) stake by 6.2% in Q2 2026, buying an estimated $47.8K and bringing the position to 11,145 shares worth $746K. The position accounts for ﹤0.01% of the portfolio, ranked #897.

HB Wealth Management first reported a position in EMN in Q3 2023 and has held it in 10 quarters since. The position peaked at $891K in Q1 2025. 647 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • HB Wealth Management held 11,145 shares of Eastman Chemical worth $746K as of Q2 2026.
  • HB Wealth Management bought 653 Eastman Chemical shares in Q2 2026, an estimated $47.8K.
  • Eastman Chemical made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #897 holding.
  • HB Wealth Management first reported a position in Eastman Chemical in Q3 2023 and has held it in 10 quarters since.
  • HB Wealth Management's Eastman Chemical position peaked at $891K in Q1 2025.
  • 647 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.